Recombinant VZV gE protein (ab43050)
Key features and details
- Expression system: Escherichia coli
- Purity: > 95% SDS-PAGE
- Tags: GST tag N-Terminus
- Suitable for: ELISA, WB
製品の詳細
-
製品名
Recombinant VZV gE protein -
生理活性
Immunoreactive with sera of VZV-infected individuals -
精製度
> 95 % SDS-PAGE.
Sepharose derived purification. -
発現系
Escherichia coli -
アクセッション番号
-
タンパク質長
Protein fragment -
Animal free
No -
由来
Recombinant -
-
予測される分子量
36 kDa including tags -
領域
48 to 135 -
タグ
GST tag N-Terminus -
配列の追加情報
The immunogen contains the VZV gE immunodominant regions
-
特性
Our Abpromise guarantee covers the use of ab43050 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
アプリケーション
ELISA
Western blot
-
製品の状態
Liquid -
Concentration information loading...
前処理および保存
-
保存方法および安定性
Shipped at 4°C. Store at -20°C.
Constituents: 0.395% Tris HCl, 0.0292% EDTA, 50% Glycerol
関連情報
-
別名
- 68
- Envelope glycoprotein E
- Glycoprotein E
see all -
関連性
This protein belongs to the herpesviruses glycoprotein E family. -
細胞内局在
Virion membrane; Single-pass type I membrane protein. Host cell membrane; Single-pass type I membrane protein. Host cell junction. Host Golgi apparatus membrane; Single-pass membrane protein. Host endosome membrane; Single-pass membrane protein
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (1)
ab43050 は 1 報の論文で使用されています。
- Petherbridge L et al. Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate. Vaccines (Basel) 11:N/A (2023). PubMed: 38006010